Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000028

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Apr 4, 2017
Accepted (ET)
Apr 6, 2017 · 12:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockApr 4, 2017P1,000$0.0104A20,032,849D
Common StockApr 4, 2017P1,000$0.093A20,033,849D
Common StockApr 4, 2017P1,000$0.097A20,034,849D
Common StockApr 4, 2017P1,000$0.099A20,035,849D
Common StockApr 4, 2017P1,000$0.0982A20,036,849D
Common StockApr 4, 2017P1,000$0.1029A20,037,849D
Common StockApr 4, 2017P1,000$0.1029A20,038,849D
Common StockApr 5, 2017P1,000$0.1149A20,039,849D
Common StockApr 5, 2017P1,000$0.1146A20,040,849D
Common StockApr 5, 2017P1,000$0.119A20,041,849D
Common StockApr 5, 2017P1,000$0.115A20,042,849D
Common StockApr 5, 2017P1,000$0.119A20,043,849D
Common StockApr 5, 2017P1,000$0.115A20,044,849D
Common StockApr 5, 2017P1,000$0.1171A20,045,849D
Common StockApr 5, 2017P1,000$0.1175A20,046,849D
Common StockApr 5, 2017P1,000$0.115A20,047,849D
Common StockApr 5, 2017P1,000$0.099A20,048,849D
Common StockApr 5, 2017P1,000$0.0982A20,049,849D
Common StockApr 5, 2017P1,000$0.096A20,050,849D
Common StockApr 5, 2017P1,000$0.096A20,051,849D
Common StockApr 5, 2017P1,000$0.094A20,052,849D
Common StockApr 5, 2017P1,000$0.088A20,053,849D
Common StockApr 5, 2017P1,000$0.088A20,054,849D
Common StockApr 5, 2017P1,000$0.088A20,055,849D
Common StockApr 5, 2017P1,000$0.094A20,056,849D
Common StockApr 5, 2017P1,000$0.0939A20,057,849D
Common StockApr 5, 2017P1,000$0.095A20,058,849D

Table II — derivative securities

No Table II lines on this filing.